Amikacin EP Impurity E is a pharmaceutical impurity reference standard used in the quality control and manufacturing of the aminoglycoside antibiotic amikacin. It serves as a reference compound for identifying and quantifying related impurities during drug development and production.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 50866-72-3
(2S)-4-Amino-N-{(1R,2S,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-4-[(6-{[(2S)-4-amino-2-hydroxybutanoyl]amino}-6-deoxy-alpha-D-glycero-hexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
research compound
(−)-ephedrine hemihydrate
pharmaceutical raw material
Mizoribine
pharmaceutical raw material
Diatrizoic acid dihydrate
pharmaceutical raw material
Procaine hydrochloride
pharmaceutical raw material
Amikacin EP Impurity G
pharmaceutical raw material
Amikacin hydrate
pharmaceutical raw material
Amikacin
antibiotic active pharmaceutical ingredient
(2S)-4-amino-N-[[(2R,3S,4S,5R,6R)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl]-2-hydroxybutanamide
PABPVMHDINVPAE-PVLUVTDWSA-N
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CNC(=O)[C@H](CCN)O)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N